Public-registry site landscape for NCT05075577, a Prostate Cancer study sponsored by ESSA Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05075577 (registry record) |
| Sponsor | ESSA Pharmaceuticals |
| Condition(s) | Prostate Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 24 |
| Site countries | United States, Australia, Canada |
Eichor generates a preliminary site-risk snapshot for NCT05075577 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →